How Scientia Clinical Research Accelerates First-In-Human Trials in Sydney?
Bringing a new medicine from the laboratory to human testing is one of the most critical and high-risk stages of drug development. First-In-Human (FIH) trials demand exceptional scientific rigor, robust safety systems, and seamless execution. In Australia, this responsibility increasingly falls on specialised research centres that combine speed, safety, and regulatory excellence. This is where Australian Clinical Research plays a global role—and where Scientia Clinical Research stands out as a trusted partner for early-phase studies in Sydney. Understanding First-In-Human (FIH) Clinical Trials First-In-Human trials are the first point at which an investigational drug or compound is administered to people rather than animals. These studies typically focus on: Safety and tolerability Pharmacokinetics (how the drug behaves in the body) Pharmacodynamics (how the drug affects the body) Dose escalation and maximum tolerated dose Because these trials involve unknown human responses, th...